Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice

Current vaccines against infectious diseases have primarily relied on attenuated or inactivated pathogens. However, self-assembled, virus-based nanoparticles (VNPs) are noninfectious multiprotein structures regarded as safe vaccine platforms for an efficient foreign antigen display within a host imm...

Full description

Bibliographic Details
Main Authors: Aliona Špakova, Indrė Dalgėdienė, Aurelija Žvirblienė, Rasa Petraitytė-Burneikienė
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Proceedings
Subjects:
Online Access:https://www.mdpi.com/2504-3900/50/1/28
id doaj-ca0f1b73bced4a3ca661886285ff4e04
record_format Article
spelling doaj-ca0f1b73bced4a3ca661886285ff4e042020-11-25T03:15:00ZengMDPI AGProceedings2504-39002020-06-0150282810.3390/proceedings2020050028Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in MiceAliona Špakova0Indrė Dalgėdienė1Aurelija Žvirblienė2Rasa Petraitytė-Burneikienė3Department of Eukaryote Gene Engineering, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaDepartment of Immunology and Cell Biology, Life Sciences Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaDepartment of Immunology and Cell Biology, Life Sciences Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaDepartment of Eukaryote Gene Engineering, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, LithuaniaCurrent vaccines against infectious diseases have primarily relied on attenuated or inactivated pathogens. However, self-assembled, virus-based nanoparticles (VNPs) are noninfectious multiprotein structures regarded as safe vaccine platforms for an efficient foreign antigen display within a host immune system. Currently, there is a low diversity of self-assembled, rod-shaped VNPs. Additionally, there is no information regarding the generation of tailed-bacteriophage nanotubes in yeast and their immunogenicity in mice. Here, we developed a novel tubular VNP-based vaccine platform utilizing a yeast-synthesized recombinant tail tube gp39 protein from bacteriophage vB_EcoS_NBD2 (NBD2). The diameter of these extremely flexible polytubes was ~12 nm, while the length varied from 0.1 µm to >3.95 µm. In this study, the immunogenicity of polytubes formed by the recombinant gp39 protein and the elicited antibody response were tested. The tubular structures formed by the recombinant gp39 protein were immunogenic in mice, although the addition of Freund’s adjuvant enhanced the anti-gp39 antibody response compared to the use of tubular structures alone. To further examine the applicability of novel polytubes as a carrier for foreign epitopes, the carboxy-terminal region within the gp39 protein was identified, allowing insertion of six histidine residues with no effect on the recombinant protein synthesis or structure self-assembly. This genetic insertion of a foreign epitope within the surface-exposed gp39 domains resulted in a repetitive display of the insert on the surface of NBD2 tail tube-originated polytubes. The combination of a repetitive, highly ordered display of foreign epitopes as well as tubular shape of nanoparticles can greatly enhance the immune response. Although more studies are needed, the flexible and extremely long polytubes formed by the recombinant tail tube gp39 protein represent a new potential platform for presenting target sequences on the exterior surface of the nanotubes.https://www.mdpi.com/2504-3900/50/1/28bacteriophage-based particlesself-assemblytubular structureepitope displayimmunogenicity
collection DOAJ
language English
format Article
sources DOAJ
author Aliona Špakova
Indrė Dalgėdienė
Aurelija Žvirblienė
Rasa Petraitytė-Burneikienė
spellingShingle Aliona Špakova
Indrė Dalgėdienė
Aurelija Žvirblienė
Rasa Petraitytė-Burneikienė
Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
Proceedings
bacteriophage-based particles
self-assembly
tubular structure
epitope display
immunogenicity
author_facet Aliona Špakova
Indrė Dalgėdienė
Aurelija Žvirblienė
Rasa Petraitytė-Burneikienė
author_sort Aliona Špakova
title Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
title_short Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
title_full Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
title_fullStr Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
title_full_unstemmed Development of a Tubular Bacteriophage-Based Vaccine Platform that Induces an Immune Response in Mice
title_sort development of a tubular bacteriophage-based vaccine platform that induces an immune response in mice
publisher MDPI AG
series Proceedings
issn 2504-3900
publishDate 2020-06-01
description Current vaccines against infectious diseases have primarily relied on attenuated or inactivated pathogens. However, self-assembled, virus-based nanoparticles (VNPs) are noninfectious multiprotein structures regarded as safe vaccine platforms for an efficient foreign antigen display within a host immune system. Currently, there is a low diversity of self-assembled, rod-shaped VNPs. Additionally, there is no information regarding the generation of tailed-bacteriophage nanotubes in yeast and their immunogenicity in mice. Here, we developed a novel tubular VNP-based vaccine platform utilizing a yeast-synthesized recombinant tail tube gp39 protein from bacteriophage vB_EcoS_NBD2 (NBD2). The diameter of these extremely flexible polytubes was ~12 nm, while the length varied from 0.1 µm to >3.95 µm. In this study, the immunogenicity of polytubes formed by the recombinant gp39 protein and the elicited antibody response were tested. The tubular structures formed by the recombinant gp39 protein were immunogenic in mice, although the addition of Freund’s adjuvant enhanced the anti-gp39 antibody response compared to the use of tubular structures alone. To further examine the applicability of novel polytubes as a carrier for foreign epitopes, the carboxy-terminal region within the gp39 protein was identified, allowing insertion of six histidine residues with no effect on the recombinant protein synthesis or structure self-assembly. This genetic insertion of a foreign epitope within the surface-exposed gp39 domains resulted in a repetitive display of the insert on the surface of NBD2 tail tube-originated polytubes. The combination of a repetitive, highly ordered display of foreign epitopes as well as tubular shape of nanoparticles can greatly enhance the immune response. Although more studies are needed, the flexible and extremely long polytubes formed by the recombinant tail tube gp39 protein represent a new potential platform for presenting target sequences on the exterior surface of the nanotubes.
topic bacteriophage-based particles
self-assembly
tubular structure
epitope display
immunogenicity
url https://www.mdpi.com/2504-3900/50/1/28
work_keys_str_mv AT alionaspakova developmentofatubularbacteriophagebasedvaccineplatformthatinducesanimmuneresponseinmice
AT indredalgediene developmentofatubularbacteriophagebasedvaccineplatformthatinducesanimmuneresponseinmice
AT aurelijazvirbliene developmentofatubularbacteriophagebasedvaccineplatformthatinducesanimmuneresponseinmice
AT rasapetraityteburneikiene developmentofatubularbacteriophagebasedvaccineplatformthatinducesanimmuneresponseinmice
_version_ 1724641133323091968